0001179110-13-002018.txt : 20130206 0001179110-13-002018.hdr.sgml : 20130206 20130206162728 ACCESSION NUMBER: 0001179110-13-002018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130204 FILED AS OF DATE: 20130206 DATE AS OF CHANGE: 20130206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gestin Denis M CENTRAL INDEX KEY: 0001423587 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12441 FILM NUMBER: 13578190 MAIL ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST. PAUL STATE: MN ZIP: 55117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ST JUDE MEDICAL INC CENTRAL INDEX KEY: 0000203077 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411276891 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE ST JUDE MEDICAL DRIVE CITY: ST PAUL STATE: MN ZIP: 55117 BUSINESS PHONE: 6517562000 MAIL ADDRESS: STREET 1: ONE ST JUDE MEDICAL DRIVE CITY: ST PAUL STATE: MN ZIP: 55117 4 1 edgar.xml FORM 4 - X0306 4 2013-02-04 0 0000203077 ST JUDE MEDICAL INC STJ 0001423587 Gestin Denis M ONE ST. JUDE MEDICAL DRIVE ST PAUL MN 55117 0 1 0 0 President, Int'l Division Common Stock 2013-02-04 4 M 0 37120 30.58 A 42712 D Common Stock 2013-02-04 4 S 0 37120 41.0686 D 5592 D Common Stock 2013-02-05 4 M 0 52880 30.58 A 58472 D Common Stock 2013-02-05 4 S 0 52880 41.4905 D 5592 D Stock Option (Right to Buy) 30.58 2013-02-04 4 M 0 37120 0 D 2009-12-15 2016-12-15 Common Stock 90000 52880 D Stock Option (Right to Buy) 30.58 2013-02-05 4 M 0 52880 0 D 2009-12-15 2016-12-15 Common Stock 52880 0 D The price in Column 4 is a weighted average. The prices actually received ranged from $41.03 to $41.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average. The prices actually received ranged from $41.42 to $41.5201. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The option shares vested 25% on each of the first four anniversary dates of the date of the grant beginning the date shown and became fully vested on December 15, 2012. /s/ Kashif Rashid, Attorney in Fact 2013-02-06